Ignite Creation Date:
2024-05-06 @ 2:03 AM
Last Modification Date:
2024-10-26 @ 11:13 AM
Study NCT ID:
NCT01967576
Status:
COMPLETED
Last Update Posted:
2021-01-06
First Post:
2013-10-19
Brief Title:
Phase II Study of Axitinib AG-013736 With Evaluation of the VEGF-pathway in Metastatic Recurrent or Primary Unresectable PheochromocytomaParaganglioma
Sponsor:
National Cancer Institute NCI
Organization:
National Institutes of Health Clinical Center CC
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-10-19
Start Date Type:
ACTUAL
Primary Completion Date:
2015-06-29
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-12-01
Completion Date Type:
ACTUAL
First Submit Date:
2013-10-19
First Submit QC Date:
October 19 2013
Study First Post Date:
2013-10-23
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2020-08-31
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-12-16
Last Update Post Date:
2021-01-06
Last Update Post Date Type:
ACTUAL